Tumor-induced osteolysis is due to recruitment and activation of osteoclasts resulting from interactions between receptor activator for nuclear factor-κB (RANK) on osteoclasts and precursors and the RANK ligand (RANKL) on osteoblasts and stromal cells [31–33]. The gene discussed is TNFRSF11A; the disease is neoplasm.